苏州蚂蚁淘生物科技有限公司是一家创新型高科技生物公司，以常规生物学实验外包与生物学试剂为基础，放眼于生命科学领域的前沿技术服务，公司技术骨干有着多年的生物学科研背景，毕业于国内外名牌大学，并且有着丰富的项目经验，了解国内外科研行情，我公司力求为每一个客户提专业、针对性的实验方案。我公司以技术服务为支点，和国内外多家生物试剂公司有着密切的业务往来.公司特色技术服务包括：抗体药物研发、噬菌体抗体库、蛋白表达与传化、抗体制备、高通量测序、组学研究、生物信息学分析与方法建立、基础分子生物学技术外包、化学中间体合成、原料药物研发、论文编写等。我公司秉承”诚信做人，认真做事，服务至上“，希望用我们的专业知识和项目经验为国内科研客户解决科研问题，祝您科研之路畅通无阻！
罗氏是全球制药和诊断领域的领导者，致力于通过推动科学进步，改善人类生活。结合了制药和诊断两大业务的独特优势使罗氏集团成为个体化医疗的领导者 - 旨在通过个体化医疗为每一位患者提供具针对性的治疗方案。
罗氏是全球领先的生物科技公司之一，罗氏在抗肿瘤、免疫、抗感染、眼科和中枢神经系统领域拥有一流的差异化药物。 罗氏在全球体外诊断和基于组织的肿瘤诊断领域享有领导地位，同时也是糖尿病管理领域的先驱者。
自 1896 年成立以来，罗氏始终致力于不断探索更好的疾病预防、诊断和治疗方案，持续为社会做出贡献。同时，公司不遗余力地与有关的利益相关方开展合作，提升患者对于创新药物的可及性。 在世界卫生组织基本药物目录中，有 29 个罗氏开发的药品，包括用以挽救生命的抗生素、抗疟药和抗肿瘤药物。罗氏连续八年位列道琼斯指数(DJSI) 制药、生物技术和生命科学领域可持续发展的全球领导者。
罗氏总部位于瑞士巴塞尔，业务遍及全球 100 多个国家及地区。2016 年，罗氏全球员工超过94,000 名，研发投资 99 亿瑞士法郎，总销售额达 506 亿瑞士法郎。美国基因泰克公司（Genentech）是罗氏集团的全资子公司。此外，罗氏也是日本中外制药株式会社（Chugai）的控股方。
A pioneer in healthcare
We have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
The frontrunner in personalised healthcare
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.
The world's largest biotech company
We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies
The global leader in cancer treatments
We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers
We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.
We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries
We are a force of over 90,000 people working together across more than 100 countries. Roche is consistently ranked as employer of choice by its employees and by external institutions
罗氏是全球制药和诊断领域的领导者，致力于通过推动科学进步，改善人类生活。结合了制药和诊断两大业务的独特优势使罗氏集团成为个体化医疗的领导者 - 旨在通过个体化医疗为每一位患者提供具针对性的治疗方案。
罗氏是全球领先的生物科技公司之一，罗氏在抗肿瘤、免疫、抗感染、眼科和中枢神经系统领域拥有一流的差异化药物。 罗氏在全球体外诊断和基于组织的肿瘤诊断领域享有领导地位，同时也是糖尿病管理领域的先驱者。
自 1896 年成立以来，罗氏始终致力于不断探索更好的疾病预防、诊断和治疗方案，持续为社会做出贡献。同时，公司不遗余力地与有关的利益相关方开展合作，提升患者对于创新药物的可及性。 在世界卫生组织基本药物目录中，有 29 个罗氏开发的药品，包括用以挽救生命的抗生素、抗疟药和抗肿瘤药物。罗氏连续八年位列道琼斯指数(DJSI) 制药、生物技术和生命科学领域可持续发展的全球领导者。
罗氏总部位于瑞士巴塞尔，业务遍及全球 100 多个国家及地区。2016 年，罗氏全球员工超过94,000 名，研发投资 99 亿瑞士法郎，总销售额达 506 亿瑞士法郎。美国基因泰克公司（Genentech）是罗氏集团的全资子公司。此外，罗氏也是日本中外制药株式会社（Chugai）的控股方。
A pioneer in healthcare
We have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
The frontrunner in personalised healthcare
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.
The world's largest biotech company
We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies
The global leader in cancer treatments
We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers
We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.
We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries
We are a force of over 90,000 people working together across more than 100 countries. Roche is consistently ranked as employer of choice by its employees and by external institutions
罗氏是全球制药和诊断领域的领导者，致力于通过推动科学进步，改善人类生活。结合了制药和诊断两大业务的独特优势使罗氏集团成为个体化医疗的领导者 - 旨在通过个体化医疗为每一位患者提供具针对性的治疗方案。
罗氏是全球领先的生物科技公司之一，罗氏在抗肿瘤、免疫、抗感染、眼科和中枢神经系统领域拥有一流的差异化药物。 罗氏在全球体外诊断和基于组织的肿瘤诊断领域享有领导地位，同时也是糖尿病管理领域的先驱者。
自 1896 年成立以来，罗氏始终致力于不断探索更好的疾病预防、诊断和治疗方案，持续为社会做出贡献。同时，公司不遗余力地与有关的利益相关方开展合作，提升患者对于创新药物的可及性。 在世界卫生组织基本药物目录中，有 29 个罗氏开发的药品，包括用以挽救生命的抗生素、抗疟药和抗肿瘤药物。罗氏连续八年位列道琼斯指数(DJSI) 制药、生物技术和生命科学领域可持续发展的全球领导者。
罗氏总部位于瑞士巴塞尔，业务遍及全球 100 多个国家及地区。2016 年，罗氏全球员工超过94,000 名，研发投资 99 亿瑞士法郎，总销售额达 506 亿瑞士法郎。美国基因泰克公司（Genentech）是罗氏集团的全资子公司。此外，罗氏也是日本中外制药株式会社（Chugai）的控股方。
A pioneer in healthcare
We have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
The frontrunner in personalised healthcare
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.
The world's largest biotech company
We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies
The global leader in cancer treatments
We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers
We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.
We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries
We are a force of over 90,000 people working together across more than 100 countries. Roche is consistently ranked as employer of choice by its employees and by external institutions
RocheX,蚂蚁淘专业代理英国各大品牌,在线下单,万余种高质量抗体,价格短,货期短,全国代理,品牌保证,价格优惠,请详询有礼,苏州蚂蚁淘生物专业代理英国罗氏X,正品保证 , 价格优惠.欢迎来询
